With these changes Phosphagenics is able toprograms, the animal health and nutrition trials and the TPM® manufacturing expansion
extend its financial runway well into 2017 improving its ability to deliver our high priority,
short to medium term later phase projects, such as the opioid patch development
answers a couple of questions...expect increased demand for tpm next year
good announcement
